Outpatient Rehabilitation Centers Market Size, Share, Growth, Trends | Report 2022-2030
The global outpatient rehabilitation centers market size was estimated at around USD 79.91 billion in 2021 and it is projected to hit around USD 147.63 billion by 2030, growing at a CAGR of 7.06% from 2022 to 2030.
Report Highlights
Growing demand for effective rehabilitation services for disabilities, drug/alcohol addiction, physical injuries, mental health, and others is expected to propel the growth of the industry during the forecast period. The cost-effective treatment compared to the inpatient rehabilitation services is expected to propel the demand for outpatient rehabilitation during the forecast period. The standard inpatient rehabilitation treatment in Canada costs around USD 10,000 to USD 20,000 per month, which is much greater compared to the USD 2,000 to USD 5,000 per month for intensive outpatient programs.
Moreover, rising government initiatives for outpatient rehabilitation centers are expected to boost the growth of the industry during the forecast period. The National Health Service (NHS) in the U.K. offers free outpatient rehabilitation treatments through community-based organizations and local health authorities. These are majorly done at the drop-in day facilities. A rise in the number of neurological disorders, such as Alzheimer’s and dementia, and a rise in the number of alcohol/drug addiction cases globally are expected to drive the growth of the industry. Companies are adopting various technologies to provide advanced services to patients. For instance, in April 2020, Kolmac Outpatient Recovery Centers launched new virtual services equipped with HIPPA-secure technology for its Intensive Outpatient Program (IOP).
Furthermore, the COVID-19 pandemic adversely affected the industry during the first wave. The market stabilized during the second and third waves. For instance, as per the article published in ScienceDirect, in Japan, the number of patients opting for outpatient rehabilitation services decreased during the first wave of the pandemic. During the second and third waves of the pandemic, the number returned to the pre-pandemic levels, which remain constant throughout the pandemic period despite the emergency declaration in Japan. Moreover, the adoption of telehealth supported the resumption of outpatient rehabilitation activities and an increase in visits to outpatient rehabilitation services.
Scope of The Report
| Report Coverage | Details |
| Market Size in 2021 | USD 79.91 billion |
| Revenue Forecast by 2030 | USD 147.63 billion |
| Growth rate from 2022 to 2030 | CAGR of 7.06% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segmentation | Therapy type, age, region |
| Companies Covered |
Forrest Health; The Mount Sinai Health System; UAB Health System; Nanz medico GmbH & Co. KG; Beijing United Family Rehabilitation Hospital (BJURH); Cambridge Medical & Rehabilitation Center; Lovelace Health System; Kimshealth Trivandrum; Unity Health Toronto; Baylor Scott & White Institute for Rehabilitation; Northern Colorado Rehabilitation Hospital (Ernest Health); Select Medical Corporation |
Therapy Type Insights
Based on therapy type, the industry is further segmented into physical, speech, occupational, behavioral, neurological, cognitive rehabilitation therapies, drug/alcohol addiction treatment, and others. The physical therapy segment dominated the overall industry in 2021 and accounted for the largest share of over 37.93% of the global revenue. The growing number of people participating in fitness programs, along with the growing number of outdoor or sports pursuits, is driving the demand for physical therapy globally. Lower back discomfort, spine, shoulder, and rotator cuff injuries, knee diseases, and other sprains & strains are the most prevalent ailments treated with physical therapy.
Moreover, with efforts to reduce overall patient costs, commercial insurers and government health programs are increasingly turning to low-cost/high-quality outpatient providers. The drug/alcohol addiction treatment segment is expected to witness a significant growth rate during the forecast period. The rising incidences of substance abuse and drug/alcohol addiction are expected to propel the demand for addiction therapy during the forecast period. As per the World Drug Report 2021, by the United Nations Office of Drug and Crime, around 66%, 17%, 42%, 60%, and 80% of people in North America, Latin America, Europe, South Africa, and Asia, respectively are consuming drugs.
Age Insights
Based on age group, the industry is further categorized into infants & toddlers, pediatric, adults, and the elderly. The adult segment led the global industry in 2021 and held the largest share of more than 45.22% of the overall revenue. The high share can be attributed to the higher chances of developing acute back pain and other orthopedic conditions, and an increasing number of accidental injuries among them. As per the World Health Organization statistics, more than 38 million Disability-Adjusted Life Years (DALY) suffered from falls and resulting in a greater number of years lived with disability. The geriatric segment is expected to witness significant growth during the forecast period.
This can be attributed to the rising geriatric population and the growing prevalence of orthopedic and chronic disorders requiring rehabilitation care. As per the World Population Ageing 2020 Highlights, United Nations, there were approximately 727 million individuals aged 65 years and above in 2020, and this number is projected to reach 1.5 billion by 2050 globally. However, the pediatric segment is expected to witness the fastest CAGR during the forecast period. The rising prevalence of accidental injuries among children and incidences of birth-related defects, such as autism spectrum disorders, motor planning disorders, premature birth, and others, are expected to propel the growth of this segment.
Regional Insights
North America dominated the global industry in 2021 and accounted for the largest share of more than 44.53% of the overall revenue. This can be attributed to the increasing number of outpatient rehabilitation centers and favorable reimbursement policies. Outpatient therapies including occupational therapy, speech-language pathology, and physical therapy are covered under Medicare Part B. Around 80% of the Medicare-approved cost of outpatient therapy is covered under original Medicare. The Asia Pacific region is expected to witness the fastest growth rate during the forecast period. This can be attributed to the rising prevalence of neurological disorders associated with disability and need for the outpatient rehabilitation care for their treatment.
For instance, as per the article published in American Heart Journal, in 2019, South-East Asia accounted for 64.4 million Disability-Adjusted Life-Years (DALY) neurological disorders and around 85 million patients in the Western-Pacific region. The more prevalent neurological disorders in the region were Alzheimer’s, migraine, stroke, and dementia. Europe is expected to hold a significant share of the market by 2030 owing to the rising substance /drug abuse cases in the region. According to the European Monitoring Centre for Drugs and Drug Addiction, in 2017, around 973,000 opted for rehabilitation treatment at outpatient specialized treatment centers.
Key Players
Market Segmentation
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Outpatient Rehabilitation Centers Market
5.1. COVID-19 Landscape: Outpatient Rehabilitation Centers Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Outpatient Rehabilitation Centers Market, By Therapy Type
8.1. Outpatient Rehabilitation Centers Market, by Therapy Type, 2022-2030
8.1.1. Physical Therapy
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Speech Therapy
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Occupational Therapy
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Behavioral Therapy
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Neurological Therapy
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Drug/Alcohol Addiction Treatment
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Cognitive Rehabilitation Therapy
8.1.7.1. Market Revenue and Forecast (2017-2030)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Outpatient Rehabilitation Centers Market, By Age
9.1. Outpatient Rehabilitation Centers Market, by Age, 2022-2030
9.1.1. Infants & Toddlers
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Pediatric
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Adults
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Elderly
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Outpatient Rehabilitation Centers Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.1.2. Market Revenue and Forecast, by Age (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.1.3.2. Market Revenue and Forecast, by Age (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.1.4.2. Market Revenue and Forecast, by Age (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.2.2. Market Revenue and Forecast, by Age (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.2.3.2. Market Revenue and Forecast, by Age (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.2.4.2. Market Revenue and Forecast, by Age (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.2.5.2. Market Revenue and Forecast, by Age (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.2.6.2. Market Revenue and Forecast, by Age (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.3.2. Market Revenue and Forecast, by Age (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.3.3.2. Market Revenue and Forecast, by Age (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.3.4.2. Market Revenue and Forecast, by Age (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.3.5.2. Market Revenue and Forecast, by Age (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.3.6.2. Market Revenue and Forecast, by Age (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.4.2. Market Revenue and Forecast, by Age (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.4.3.2. Market Revenue and Forecast, by Age (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.4.4.2. Market Revenue and Forecast, by Age (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.4.5.2. Market Revenue and Forecast, by Age (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.4.6.2. Market Revenue and Forecast, by Age (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.5.2. Market Revenue and Forecast, by Age (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.5.3.2. Market Revenue and Forecast, by Age (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Therapy Type (2017-2030)
10.5.4.2. Market Revenue and Forecast, by Age (2017-2030)
Chapter 11. Company Profiles
11.1. Forrest Health
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. The Mount Sinai Health System
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. UAB Health System
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Nanz medico GmbH & Co. KG
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Beijing United Family Rehabilitation Hospital (BJURH)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Cambridge Medical & Rehabilitation Center
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Lovelace Health System
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Kimshealth Trivandrum
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Unity Health Toronto
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Baylor Scott & White Institute for Rehabilitation
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers